Quad-C Sells Specialty Chemicals Maker Boulder Scientific to Iron Path Capital

Quad-C Management has closed the sale of Boulder Scientific Company to Iron Path Capital, handing the 60-plus-year-old specialty chemicals manufacturer a new private equity owner after a run of capacity expansion and market diversification.

The Longmont, Colorado-based company manufactures high-performance organometallic compounds and delivers complex synthetic chemistry capabilities. Its compounds serve primarily as metallocene catalysts in polyolefin production. The product line also covers activators, ligands, air- and moisture-sensitive compounds, pyrophoric materials and other co-catalysts, shipped to international customers from two Colorado facilities.

Boulder Scientific's customer base spans six end markets: plastics, microelectronics, pharmaceutical, industrial, defense, and aerospace. That breadth is the result of deliberate work under Quad-C's ownership.

How the deal came together

Quad-C initially partnered with Boulder Scientific's founding family and management to transition the business out of family ownership. During the hold, the firm strengthened the leadership team and poured substantial capital into production facilities.

Those investments expanded manufacturing capacity and technical capabilities, letting the company serve a wider set of customers and end markets. Boulder Scientific increased its exposure to semiconductor materials and to aerospace and defense, while keeping its established specialty chemicals base intact.

CEO Rich Preziotti credited the outgoing owner directly. "Quad-C has been an exceptional partner, providing the resources and strategic support that positioned us to grow and expand into new markets," Preziotti said. He added: "Boulder Scientific's chemistry is truly differentiated, and in partnership with the Quad-C team, we have strengthened the company's global market position while maintaining our technical excellence and commitment to quality and safety."

What does this change for the company?

In practical terms, ownership shifts, but the strategic thesis stays the same. Iron Path Capital's acquisition opens what Quad-C calls the next phase of Boulder Scientific's development. The company's specialized chemistry expertise and demanding manufacturing requirements create technical barriers to entry — a moat any new owner will want to protect. Demand from semiconductor, aerospace, defense and advanced materials customers gives the business several distinct growth avenues.

For Quad-C, the exit continues a sector pattern rather than ending it. "Boulder Scientific is a differentiated company in the specialty chemicals industry," said Anders Grorud, Vice President at Quad-C. "Quad-C has a long history of successful investments in the sector, and this continues to be an area of focus."

Tom Hickey, Senior Partner at Quad-C, framed the farewell personally. "It has been a privilege to partner with Rich, Scott Birmingham, and the entire Boulder Scientific team," Hickey said. "We believe that Boulder Scientific's unique technical capabilities in organometallic and complex synthetic chemistry position the company to drive growth and we wish them continued success in their next phase."

The seller's track record

Quad-C, headquartered in Charlottesville, Virginia, is a middle-market private equity firm focused on established industrial and services companies. Since its founding in 1989, it has invested more than $5 billion across 92 platform companies and over 425 add-on acquisitions — roughly $54 million per platform deal on average, a useful yardstick for the middle-market scale it plays in.

Deal advisers were named. Piper Sandler served as Boulder Scientific's exclusive financial adviser, and White & Case provided legal counsel.

Financial terms weren't disclosed. What practitioners should watch now: whether Iron Path pushes deeper into semiconductor-grade materials, the fastest-moving of Boulder Scientific's growth markets, and whether Quad-C recycles proceeds into another specialty chemicals platform given its stated continued focus on the sector.